UPDATE 1-Sanofi, Regeneron arthritis drug meets goals in Phase 3 trial
November 22, 2013 at 01:29 AM EST
PARIS, Nov 22 (Reuters) - An experimental drug for rheumatoid arthritis developed by French drugmaker Sanofi and Regeneron, when combined with methotrexate, improved symptoms and physical function and slowed progression of the disease in a late-stage clinical trial.
